article thumbnail

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

Digital Health Global

As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development.

article thumbnail

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

Collaborate with Experts: Collaborate with healthcare experts and data specialists to continuously refine the FDP and ensure it meets the evolving needs of the NHS. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Buy, build or partner?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Healthcare IT Today

SeedtoB invests where technological innovation meets a mission-driven mindset which is what made participation in AngelEye Health’s Series B an attractive opportunity for our firm,” said Eller Kelliher , Partner at SeedtoB. “By Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic Drug Development.

article thumbnail

A guide to connected health device and remote patient monitoring vendors

Healthcare IT News - Telehealth

Employers and payers may offer telehealth options that allow the team member to meet with their doctor via video. iRhythm Technologies. iRhythm is a healthcare technology company that clinically diagnoses cardiac arrhythmias by combining wearable biosensing technology with cloud-based data analytics and machine learning capabilities.